Lin Wu - Publications, H-index & Citations

Lin Wu

central south university

59H指数

472论文数

1.7W被引数

收录论文 149

发表时间

Oral KRAS G12D inhibitor GFH375 for previously treated advanced solid tumors with KRASG12D mutations: a phase 1 trial 口服KRAS G12D抑制剂GFH375用于既往治疗过的KRASG12D突变晚期实体瘤：一项1期临床试验

Nature Medicine

IF50

2026-09-15

PREAI

Xinghao Ai; Zhengbo Song; Lin Wu; Aiping Zhou; Di Cheng; Hong Zong; Heshui Wu; Zuoxing Niu; Yuping Sun; Lingjun Zhu; Zhiwei Li; Yanhong Deng; Ying Yuan; Xiujuan Qu; Haitao Zhao; Yingying Du; Ziming Li; Yu Wang; Haige Shen; Huaqiang Zhu; Chanli Zheng; Shuang Wang; Zhao Cui; Lingyu Tai; Shun Lu

Targeting DNA damage signaling in atherosclerosis: molecular mechanisms and therapeutic opportunities 靶向动脉粥样硬化中的DNA损伤信号：分子机制和治疗机遇

Molecular Medicine

IF6.4

2026-08-27

OAAI

Hua Ye; Yushan Li; Yiran E. Li; Runyang Feng; Yanmei Liu; Jiajin Tu; Lin Wu

Real-world evidence of immunotherapy in older adults with advanced non-small cell lung cancer: a retrospective cohort study 老年晚期非小细胞肺癌患者免疫治疗的真实世界证据：一项回顾性队列研究

Cancer Immunology Immunotherapy

IF5.1

2026-08-07

OAAI

Yuling Zhong; Jingyi Wang; Bolin Chen; Yan Xu; Li Xu; Jia Li; Fang Xu; Qianzhi Wang; Kang Li; Yi Kong; Liyu Liu; Yini Liang; Mei Peng; Lin Wu

Real-world serplulimab plus chemotherapy for extensive-stage small cell lung cancer in china: an external validation of ASTRUM-005 trial 中国真实世界中度小细胞肺癌患者接受赛普利姆单抗联合化疗治疗的疗效：ASTRUM-005试验的外部验证

BMC Medicine

IF8.3

2026-07-15

OAAI

Lin Wu; Chengping Hu; Wenzhong Su; Hui Zhu; Wei Hong; Haichuan Su; Yan Yu; Tao Luo; Zhigang Liu; Zhentian Liu; Qing Pu; Caixia Wang; Xuhong Min; Hui Guo; Yifei Chen

Gotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trial 在转移性鳞状非小细胞肺癌中使用clotistobart或多西他赛: 随机3期PRESERVE-003试验的1期

Nature Medicine

IF50

2026-03-27

OAAI

Byoung Chul Cho; Rama Balaraman; Hua-Jun Chen; Xinmin Yu; Adewale Fawole; Zhi-gang Liu; Jiliang Zhang; Long Wu; Bin Yang; Jennifer L. Leddon; John Hamm; Yanjing Huang; Lin Wu; Pinhua Pan; Preet Singh; Andrew Beardsley; Fadi Kayali; Ardalan Davarifar; Ki Hyeong Lee; Keon-Uk Park; Youngjoo Lee; Luchun Li; Xicheng Wang; Meili Sun; Yan Yu; Vikram Jain; Svetlana Shpyro; Qiong Wang; Michael Wenger; Uğur Şahin; Sergey Efuni; Shiling Song; Kun He; Pan Zheng; Yang Liu; Kai He; Tianhong Li; Mark A. Socinski; Yi-Long Wu

First-line Aumolertinib (EGFR tyrosine kinase inhibitor) plus apatinib (VEGFR inhibitor) versus aumolertinib in EGFR-mutant non-small cell lung cancer patients: a randomized, multicenter, phase II trial 一线Aumolertinib (EGFR酪氨酸激酶抑制剂) 联合阿帕替尼 (VEGFR抑制剂) 与aumolertinib在EGFR突变的非小细胞肺癌患者中的比较: 一项随机，多中心，II期试验

Signal Transduction and Targeted Therapy

IF52.7

2026-02-02

OAAI

Fan Zhang; Zhendong Zheng; Hongmei Zhang; Xiaolong Yan; Zhefeng Liu; Fan Yang; Juyi Wen; Xin Gan; Lin Wu; Shundong Cang; Hongmei Wang; Jun Zhao; Liang Peng; Xiaosong Li; Zaiwen Fan; Ge Shen; Qiong Zhou; Jinjing Zou; Yu Xu; Lei Zhang; Mingfang Zhao; Shangli Cai; Yi Hu

PACIFIC-5: a phase III clinical trial of consolidation durvalumab in patients with unresectable stage III NSCLC and no progression after concurrent or sequential chemoradiotherapy PACIFIC-5: 在不可切除的III期NSCLC患者中巩固durvalumab的III期临床试验，同时或序贯放化疗后无进展

Journal of Hematology & Oncology

IF40.4

2025-12-07

OAAI

Yi-Long Wu; Lin Wu; Nan Bi; Timucin Cil; Hong Ge; Zhengfei Zhu; Chih-Liang Wang; Wei Zhang; Dongqing Lv; E. Mingyan; Jianguo Sun; Yi Pan; Maciej Krzakowski; Mustafa Dikilitas; Mehmet Ali Nahit Sendur; Young-Chul Kim; Yanjiao Yang; Rui Mao; Biao Zhang; Luhua Wang

Stiffness-Tunable Hydrogel Microfluidic Chip Reveals the Role of Stiffness in Cholangiocarcinoma Invasion and Pre-Metastatic Niche Formation 刚度可调水凝胶微流控芯片揭示了刚度在胆管癌侵袭和前转移灶形成中的作用

Advanced Healthcare Materials

IF9.6

2025-11-30

PREAI

Lin Wu; Guohua Wu; Di Wu; Wenqi Hu; Qijun Du; Qinrui Lu; Jiashu Wang; Ao Xie; Youlong Yang; Jie Liu; Wenlong Zhang; Chengwei Sun; Bangchuan Hu; Zipeng Yao; Hongbin Deng; Mengjiao Xia; Haijie Hu; Shuqi Wang

Real-world use of and clinical outcomes with dacomitinib as first-line therapy in Asian patients with EGFR mutation–positive locally advanced or metastatic non-small cell lung cancer: Final analysis of the ARIA study 达可替尼作为亚洲表皮生长因子受体（EGFR）突变阳性局部晚期或转移性非小细胞肺癌患者的一线疗法：ARIA研究的最终分析

Lung Cancer

IF4.4

2025-11-25

PREAI

Lin Wu; Junling Li; Chong-Rui Xu; Bivas Biswas; Somnath Roy; Ke-Jing Tang; Huijuan Wang; Ziling Liu; Ullas Batra; Gwo Fuang Ho; John Low Seng Hooi; You Lu; Mingfang Zhao; Lye Mun Tho; Jun Zhao; Shan He; Joan Huang; Hui Zhang; Chew Hooi Wong; Yi-Long Wu

TROP-2-targeted antibody-drug conjugate SHR-A1921 for advanced or metastatic solid tumors: A first-in-human phase 1 study TROP-2靶向抗体药物偶联物SHR-A1921治疗晚期或转移性实体瘤：一项首次人体1期研究

Cancer Cell

IF44.5

2025-10-23

PREAI

Jia Zhong; Lin Wu; Zhengbo Song; Nianzeng Xing; Jiujie Cui; Xingya Li; Kailun Fei; Dihong Tang; Qi Dang; Liang Chen; Tianshu Liu; Caigang Liu; Yong Li; Shichuan Zhang; Xinghua Han; Juxiang Xiao; Feng Guo; Min Yan; Huiting Xu; Chunxiu Yuan; Jincai Zhong; Rongrui Liu; Xiujuan Qu; Shikai Wu; Shusuan Jiang; Yan Yang; Panpan Zhang; Hongqian Guo; Ce Wang; Qiushi Xie; Zhifei Lin; Shuni Wang; Jie Wang

Efficacy and safety of glecirasib in solid tumors with KRAS G12C mutation: A pooled analysis of two phase I/II trials glecirasib在KRAS G12C突变实体瘤中的有效性和安全性：两项I/II期试验的合并分析

Cancer Communications

IF24.9

2025-10-02

OAAI

Jian Li; Ting Deng; Yanhong Gu; Antonio Calles Blanco; Zhihua Li; Chunmei Bai; Lin Wu; Jing Huang; Xingya Li; Yu Yao; Zhengbo Song; Yongsheng Li; Lian Liu; Ligang Xing; Wenming Wu; Julia Martínez-Pérez; Ayala Hubert; Jon Zugazagoitia; Jian Zhang; Yongsheng Wang; Yanqiu Zhao; Guilan Wen; Guohao Xia; Diansheng Zhong; Xueqin Chen; Kuirong Jiang; Andrea Wang-Gillam; Yuli Ding; Sumei Liu; Zhiyue Rao; Xinghu Liu; Lin Shen

Sevabertinib in Advanced HER2-Mutant Non-Small-Cell Lung Cancer Sevabertinib治疗晚期HER2-Mutant非小细胞肺癌

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2025-10-01

PREAI

Le, Xiuning; Kim, Tae Min; Loong, Herbert H.; Prelaj, Arsela; Goh, Boon Cher; Li, Lin; Fang, Yong; Lu, Shun; Dong, Xiaorong; Wu, Lin; Shinno, Yuki; Daniele, Gennaro; Yang, Tsung-Ying; Kim, Hye Ryun; Ruiter, Gerrina; Zhao, Jun; Novello, Silvia; Miao, Liyun; Janne, Pasi A.; Goto, Koichi; Ruttinger, Dominik; Descamps, Tine; Brase, Jan Christoph; Bao, Weichao; Li, Rui; Brega, Nicoletta; Grassi, Paolo; Girard, Nicolas; Tan, Daniel Shao-Weng

Safety and efficacy of YK-029A in previously treated EGFR T790M-Mutant NSCLC: A multi-center phase I trial YK-029A在既往治疗过的EGFR T790M突变型NSCLC中的安全性与有效性：一项多中心I期临床试验

Lung Cancer

IF4.4

2025-09-23

OAAI

Xinyu Wu; Rui Wan; Lin Wu; Mingfang Zhao; Yanqiu Zhao; Xiumei Dai; Jun Zhao; Zhe Liu; Yanyan Xie; Yueyin Pan; Zhihong Zhang; Yu Yao; Kunyu Yang; Bi Chen; Jie Wang; Jianchun Duan

First-line sacituzumab tirumotecan with tagitanlimab in advanced non-small-cell lung cancer: a phase 2 trial 一线sacituzumab tirumotecan联合tagitanlimab治疗晚期非小细胞肺癌：一项Ⅱ期临床试验

Nature Medicine

IF50

2025-08-19

PREAI

Shaodong Hong; Qiming Wang; Ying Cheng; Yongzhong Luo; Xiujuan Qu; Haibo Zhu; Zhenyu Ding; Xingya Li; Lin Wu; Yan Wang; Sheng Hu; Enwen Wang; Anwen Liu; Yuping Sun; Yun Fan; Feng Ye; Kaihua Lu; Jian Fang; Yuping Shen; Xiaoping Jin; Junyou Ge; Li Zhang; Wenfeng Fang

Comparison of the analgesic effects of ultrasound-guided erector spinae plane block and quadratus lumborum block: a systematic review and meta-analysis 超声引导下 Erector Spinae 平面阻滞与 Quadratus Lumborum 阻滞镇痛效果的比较：一项系统评价和荟萃分析

Frontiers in Pharmacology

IF4.8

2025-08-02

OAAI

Lin Wu†; Weiyi Zhang†; Yiyong Wei; Donghang Zhang

First-line serplulimab plus chemotherapy in extensive-stage small-cell lung cancer: Updated results and biomarker analysis from the ASTRUM-005 randomized clinical trial 一线serplulimab联合化疗治疗广泛期小细胞肺癌：ASTRUM-005随机临床试验的更新结果与生物标志物分析

Cancer Communications

IF24.9

2025-05-29

OAAI

Ying Cheng; Shuang Zhang; Liang Han; Lin Wu; Jun Chen; Peiyan Zhao; Hongmei Sun; Guilan Wen; Yinghua Ji; Anastasia Zimina; Jianhua Shi; Zhijie Pan; Jinsheng Shi; Xicheng Wang; Yuansong Bai; Tamar Melkadze; Yueyin Pan; Xuhong Min; Maksym Viguro; Xingya Li; Yanqiu Zhao; Junquan Yang; Tamta Makharadze; Ekaterine Arkania; Haoyu Yu; Jing Li; Fang Yang; Xinyi Yang; Chen Ling; Qingyu Wang; Yongqiang Shan; Jun Zhu; the ASTRUM-005 Study Group

Harnessing local and system immune profiling delineating differential responders to first-line sintilimab (anti-PD-1 antibody) combined with chemotherapy in extensive-stage small cell lung cancer: an exploratory biomarker analysis of a phase II study 利用局部和系统性免疫特征分析，区分广泛期小细胞肺癌中接受一线信迪利单抗（anti-PD-1抗体）联合化疗的不同应答者：一项Ⅱ期研究的探索性生物标志物分析

SIGNAL TRANSDUCTION AND TARGETED THERAPY

IF52.7

2025-05-23

OAAI

Xie, Mengqing; Bao, Minwei; Dong, Xiaorong; Wu, Lin; Liu, Li; Zhao, Jing; Chu, Xiangling; Wu, Yan; Ji, Xianxiu; Fang, Yujia; Yu, Xin; Zhang, Shiji; Wang, Qi; Hu, Tao; Wang, Jin; Zhu, Changbin; Su, Chunxia

Anlotinib Plus Docetaxel is Promising in Advanced NSCLC Progressing on First-Line Immunotherapy: A Pooled Analysis of Two Randomized Trials 阿尼洛替尼联合多西他赛在进展期非小细胞肺癌一线免疫治疗进展患者中前景良好：两项随机试验的合并分析

ADVANCES IN THERAPY

IF4

2025-05-12

PREAI

Pu, XX; Shou, JW; Xiao, ZM; Chen, J; Xiao, ML; Guo, QY; Ma, ZX; Hong, W; Wang, QZ; Wang, YH; Li, J; Rao, CZ; Weng, J; Lu, LQ; Wu, L; Fang, Y

Potential biomarkers of primary resistance to first- and second-generation EGFR-TKIs in non-small-cell lung cancer: a real-world study 非小细胞肺癌对第一代和第二代EGFR-TKIs的原发耐药的潜在生物标志物：一项真实世界研究

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY

IF4.2

2025-04-30

OAAI

Jingyi Wang; Bolin Chen; Xingxiang Pu; Jia Li; Yan Xu; Li Xu; Fang Xu; Kang Li; Yi Kong; Liyu Liu; Qianzhi Wang; Lin Wu